Label Image (Lbl500907919)
Shingrix Injection, Solution
Product Images NDC 50090-7919
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Shingrix (NDC 50090-7919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Shingrix Spl Graphic 01)
Figure 2 (Shingrix Spl Graphic 02)
This description appears to refer to a lyophilized gE antigen component in powder form. This component could potentially be used in various diagnostic tests, research applications, or as part of a vaccine formulation for diseases where gE antigen is relevant. The lyophilized form indicates that the antigen has been freeze-dried for preservation and stability.*
Figure 3 (Shingrix Spl Graphic 03)
Figure 4 (Shingrix Spl Graphic 04)
This is information about a reconstituted vaccine that should be administered in 0.5mL dosage.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
